Restrospective Analysis of MACE in Patients Treated With Drug-elluting Balloons.

Recruiting now

Conditions studied: Coronary Arterial Disease (CAD), Restenosis, Coronary, Bifurcation Coronary Disease

In brief

Retrospective analysis of data collected in an institutional database of coronary interventions with use of drug-eluting balloons, with a prospective follow-up for major adverse cardiovascular events and living status.

Key facts

Study ID

NCT06972225

Run by

Olivier F. Bertrand

People needed

1500

Starts

2025-06-10

Expected to finish

2036-03-01

Last updated by the study team

2026-04-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults (>=18 years of age)
• Who underwent a coronary angioplasty with drug-eluting balloon between January 2010 and December 2025
• Identified in the institutional procedure database

You may not qualify if…

• Incomplete or non-available data on the post-procedural clinical follow-up
• Procedures where other devices were used in combination with drug-eluting balloons.

Where it is running

• IUCPQ — Québec, Quebec, Canada (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.